New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health records of more than 6,000 obese patients with Type 2 diabetes, half of whom ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Weight loss jabs could cut cancer risk by almost half and be given to people who are not obese, scientists say. Landmark research appears to confirm the appetite-suppressing jabs which mimic a ...

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

Weight loss jabs could “herald a whole new era of preventative cancer medicine” by slashing risk of obesity-related tumours, experts have said. Research presented at the European Congress on ...